• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Titus Stuart W

    5/31/23 4:24:54 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $HPCO alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Titus Stuart W

    (Last) (First) (Middle)
    9925 AIRWAY ROAD

    (Street)
    SAN DIEGO CA 92154

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Hempacco Co., Inc. [ HPCO ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    03/29/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Rule 10b5-1(c) Transaction Indication

      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 03/29/2023 P(1) 216,211 A $0.4995 316,211 D
    Common Stock 05/10/2023 P(2) 10,000 A $0.62 326,211 D
    Common Stock 05/10/2023 P(2) 9,916 A $0.605 336,127 D
    Common Stock 05/11/2023 P(2) 10,000 A $0.61 346,127 D
    Common Stock 05/11/2023 P(2) 10,000 A $0.605 356,127 D
    Common Stock 05/12/2023 P(2) 10,000 A $0.57 366,127 D
    Common Stock 05/17/2023 P(2) 10,000 A $0.5799 376,127 D
    Common Stock 05/19/2023 P(2) 10,000 A $0.57 386,127 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Private purchase from Green Globe International, Inc. (pursuant to which shares were acquired from Green Globe International, Inc. ("GGII") in consideration of Dr. Titus's agreement to consider $108,000 in principal and interest owed to Dr. Titus by GGII under the short-term loan he made to GGII paid in full).
    2. Open market purchase.
    Remarks:
    /s/ Stuart Titus 05/31/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HPCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HPCO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HPCO
    Leadership Updates

    Live Leadership Updates

    See more
    • Hempacco Announces Opening of European Office as Part of International Expansion Strategy

      Jakub Duda appointed Country Manager of Hempacco EuropeSan Diego, California--(Newsfile Corp. - April 4, 2023) - Hempacco Co, Inc. (NASDAQ:HPCO) ("Hempacco"), a hemp smokables company Disrupting Tobacco's™ nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, today announced the opening of its European office as part of its international expansion strategy. Hempacco Europe, SP. Z O.O., located in Warsaw, Poland, will be the company's new European subsidiary.This follows the company's appointment of Jakub Duda as Country Manager of Hempacco Europe. Jakub is a creative Business Development Manager with over ten years of experience leading intern

      4/4/23 9:00:00 AM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hempacco Receives Notification of Deficiency from Nasdaq

      San Diego, California--(Newsfile Corp. - May 31, 2024) - Hempacco Co., Inc. (NASDAQ:HPCO) ("Hempacco" or the "Company"), a vertically integrated hemp manufacturing company, announced today that on May 23, 2024, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Quarterly Report").The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.

      5/31/24 4:12:00 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • New to The Street Airs Episode 572 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network, Monday, May 6, 2024, at 10:30 PM PT

      NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television production, announces airing Episode 572 on the FOX Business Network on Monday, May 6, 2024, at 10:30 PM PT. New to The Street's Episode 572 line-up features the following Five (5) Corporate interviews: 1). Labor Relations Firm - Greer Consulting, Inc.'s (GCI) interview with Jason Greer, Founder/CEO. 2). New to The Street's "Game Changers" with TV Host Ana Berry talking with Jorge Olson, Chief Marketing Officer (CMO), Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) and Brad Wyatt, Chief Executive Officer, Illumination Brands, Inc. 3). Digital Marketing- Banzai Int

      5/6/24 9:30:00 AM ET
      $BNZI
      $HPCO
      $LRHC
      Computer Software: Prepackaged Software
      Technology
      Medicinal Chemicals and Botanical Products
      Health Care
    • New to The Street and Hempacco Co., Inc. Sign Three Month Media Contract

      NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- New to The Street and Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) ("Hempacco") signed a three-month media contract. The agreement calls for the continuation of filming and broadcasting tailored interviews and streaming digital billboard aids in New York City. The contract calls for the New to the Street's TV news host to interview key corporate representatives from Hempacco Co., Inc. Each week over the next three months, New to The Street's Hempacco interviews will air on the FOX Business Network as sponsored programming. New to The Street's TV hosts will provide in-depth interviews with HPCO's management team with focused discuss

      3/28/24 9:15:00 AM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    SEC Filings

    See more
    • Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      10/10/24 5:00:29 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      9/9/24 12:45:38 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      8/23/24 4:51:27 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Titus Stuart W

      4 - Hempacco Co., Inc. (0001892480) (Issuer)

      5/31/23 4:24:54 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 3: New insider Titus Stuart W claimed ownership of 100,000 shares

      3 - Hempacco Co., Inc. (0001892480) (Issuer)

      5/31/23 4:24:18 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care